156 related articles for article (PubMed ID: 32369961)
41. Systemic administration of quality- and quantity-controlled PBMNCs reduces bisphosphonate-related osteonecrosis of jaw-like lesions in mice.
Kuroshima S; Nakajima K; Sasaki M; I T; Sumita Y; Asahara T; Asahina I; Sawase T
Stem Cell Res Ther; 2019 Jul; 10(1):209. PubMed ID: 31311585
[TBL] [Abstract][Full Text] [Related]
42. Effects of dexamethasone and nimesulide on bisphosphonate-related osteonecrosis of the jaw: An experimental study.
Oliveira CC; Barros Silva PG; Ferreira AEC; Gonçalves RP; Sousa FB; Mota MRL; Alves APNN
Arch Oral Biol; 2017 Nov; 83():317-326. PubMed ID: 28869827
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of the therapeutic effects of conditioned media from mesenchymal stem cells in a rat bisphosphonate-related osteonecrosis of the jaw-like model.
Ogata K; Katagiri W; Osugi M; Kawai T; Sugimura Y; Hibi H; Nakamura S; Ueda M
Bone; 2015 May; 74():95-105. PubMed ID: 25613174
[TBL] [Abstract][Full Text] [Related]
44. Structural requirements for bisphosphonate binding on hydroxyapatite: NMR study of bisphosphonate partial esters.
Puljula E; Turhanen P; Vepsäläinen J; Monteil M; Lecouvey M; Weisell J
ACS Med Chem Lett; 2015 Apr; 6(4):397-401. PubMed ID: 25893039
[TBL] [Abstract][Full Text] [Related]
45. Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: A trigger for BRONJ development?
Otto S; Tröltzsch M; Jambrovic V; Panya S; Probst F; Ristow O; Ehrenfeld M; Pautke C
J Craniomaxillofac Surg; 2015 Jul; 43(6):847-54. PubMed ID: 25958767
[TBL] [Abstract][Full Text] [Related]
46. Altered macrophagic THP-1 cell phagocytosis and migration in bisphosphonate-related osteonecrosis of the jaw (BRONJ).
Hoefert S; Sade Hoefert C; Munz A; Northoff H; Yuan A; Reichenmiller K; Reinert S; Grimm M
Clin Oral Investig; 2016 Jun; 20(5):1043-54. PubMed ID: 26349768
[TBL] [Abstract][Full Text] [Related]
47. Impact of Soft Tissue Pathophysiology in the Development and Maintenance of Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ).
Ziebart T; Halling F; Heymann P; Neff A; Blatt S; Jung J; Pabst A; Righesso L; Walter C
Dent J (Basel); 2016 Oct; 4(4):. PubMed ID: 29563478
[TBL] [Abstract][Full Text] [Related]
48. Synthetic Calcium Phosphate Ceramics as a Potential Treatment for Bisphosphonate-Related Osteonecrosis of the Jaw.
Paulo S; Laranjo M; Abrantes AM; Casalta-Lopes J; Santos K; Gonçalves AC; Paula AB; Marto CM; Sarmento-Ribeiro AB; Carrilho E; Serra A; Botelho MF; Ferreira MM
Materials (Basel); 2019 Jun; 12(11):. PubMed ID: 31174333
[TBL] [Abstract][Full Text] [Related]
49. Role of intravenous dosage regimens of bisphosphonates in relation to other aetiological factors in the development of osteonecrosis of the jaws in patients with myeloma.
Jarnbring F; Kashani A; Björk A; Hoffman T; Krawiec K; Ljungman P; Lund B
Br J Oral Maxillofac Surg; 2015 Dec; 53(10):1007-11. PubMed ID: 26530732
[TBL] [Abstract][Full Text] [Related]
50. Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity?
Reid IR; Bolland MJ; Grey AB
Bone; 2007 Sep; 41(3):318-20. PubMed ID: 17572168
[TBL] [Abstract][Full Text] [Related]
51. Pamidronate enhances bacterial adhesion to bone hydroxyapatite. Another puzzle in the pathology of bisphosphonate-related osteonecrosis of the jaw?
Kos M; Junka A; Smutnicka D; Bartoszewicz M; Kurzynowski T; Gluza K
J Oral Maxillofac Surg; 2013 Jun; 71(6):1010-6. PubMed ID: 23489958
[TBL] [Abstract][Full Text] [Related]
52. Hematopoietic Cell Transplantation in Patients with Medication-Related Osteonecrosis of the Jaws.
Mawardi H; Glotzbecker B; Richardson P; Woo SB
Biol Blood Marrow Transplant; 2016 Feb; 22(2):344-348. PubMed ID: 26303103
[TBL] [Abstract][Full Text] [Related]
53. Bisphosphonate-related osteonecrosis of jaw (BRONJ) in Japanese population: a case series of 13 patients at our clinic.
Nomura T; Shibahara T; Uchiyama T; Yamamoto N; Shibui T; Yakushiji T; Watanabe A; Muramatsu K; Ogane S; Murayama M; Sekine R; Nakata E; Fujimoto Y
Bull Tokyo Dent Coll; 2013; 54(2):117-25. PubMed ID: 23903583
[TBL] [Abstract][Full Text] [Related]
54. [Position paper on medication-related osteonecrosis of the jaw (MRONJ)].
Svejda B; Muschitz Ch; Gruber R; Brandtner Ch; Svejda Ch; Gasser RW; Santler G; Dimai HP
Wien Med Wochenschr; 2016 Feb; 166(1-2):68-74. PubMed ID: 26847441
[TBL] [Abstract][Full Text] [Related]
55. Influence of induced infection in medication-related osteonecrosis of the jaw development after tooth extraction: A study in rats.
Bolette A; Lecloux G; Rompen E; Albert A; Kerckhofs G; Lambert F
J Craniomaxillofac Surg; 2019 Feb; 47(2):349-356. PubMed ID: 30595476
[TBL] [Abstract][Full Text] [Related]
56. Incidence of bisphosphonate-related osteonecrosis of the jaw in consideration of primary diseases and concomitant therapies.
Assaf AT; Smeets R; Riecke B; Weise E; Gröbe A; Blessmann M; Steiner T; Wikner J; Friedrich RE; Heiland M; Hoelzle F; Gerhards F
Anticancer Res; 2013 Sep; 33(9):3917-24. PubMed ID: 24023329
[TBL] [Abstract][Full Text] [Related]
57. Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management.
Grewal VS; Fayans EP
Todays FDA; 2008 Aug; 20(8):38-41, 43-6. PubMed ID: 18767452
[TBL] [Abstract][Full Text] [Related]
58. Epidemiology, pharmacology and clinical characterization of bisphosphonate-related osteonecrosis of the jaw. A retrospective study of 70 cases.
Pelaz A; Junquera L; Gallego L; García-Consuegra L; García-Martínez L; Cutilli T; Olay S
Acta Otorrinolaringol Esp; 2015; 66(3):139-47. PubMed ID: 25308796
[TBL] [Abstract][Full Text] [Related]
59. Bisphosphonate and Medication-Related Osteonecrosis of the Jaw: A Review.
Mücke T; Krestan CR; Mitchell DA; Kirschke JS; Wutzl A
Semin Musculoskelet Radiol; 2016 Jul; 20(3):305-314. PubMed ID: 27741546
[TBL] [Abstract][Full Text] [Related]
60. Radiographic bone loss and the risk of medication-related osteonecrosis of the jaw (MRONJ) in multiple myeloma patients-A retrospective case control study.
Wazzan T; Kashtwari D; Almaden WF; Gong Y; Chen Y; Moreb J; Katz J
Spec Care Dentist; 2018 Nov; 38(6):356-361. PubMed ID: 30194738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
